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Cancer Council statistics show that Australia has the highest rate of skin cancer in the 
world (twice that of the USA and UK), and predicts 2 in 3 Australians will be 
diagnosed with skin cancer before the age of 70. Tumour-specific CD8
+
 T-cells are 
well-recognised for their importance in eliciting tumour-rejection, however, in many 
cases tumour-specific CD8
+
 T-cells within the tumour microenvironment are 
dysfunctional.  The regulation of CD8
+
 T-cell activity in the tumour 
microenvironment is poorly understood.  This study aimed to explore the mechanisms 
involved in the regulation of CD8
+
 T-cells in the skin as a prelude to tumour studies.  
We have generated a new experimental mouse model in which activated CD8β+ T-
cells from donor mice were introduced into RAG1KO mice in order to assess CD8
+
 
T-cell deregulation in the absence of conventional-regulatory T-cells (Treg).  When 
RAG1KO mice subsequently received CD4-depleting antibody, CD8
+
 T-cell-
mediated destruction of the ear skin occurred. However, this did not occur in mice 
administered control-antibody.  Analysis of lymph nodes 30 days post CD8β+ T-cell 
transfer showed no evidence of classical CD4
+
FoxP3
+
 Treg indicating regulation is 
mediated by a separate, distinct cell type.  Using the model, we have identified CD4
+ 
cells, which are distinct from classical-Treg, and we are subsequently defining the 
mechanism by which these cells exert control of CD8
+
 T-cell function in the skin.  
Uncovering novel pathways of CD8
+
 T-cell regulation will shed new light onto 
regulatory influences of CD8
+
 T-cell function within tumours and yield opportunities 
to develop better treatment options for cancer patients. 
 
